[Speaker]
Dong Oh Kang
Dong Oh Kang, MD, PhD1,2, Yong Geun Lim, BA3, Yeon Hoon Kim, BS4, Joon Woo Song, PhD1, Ye Hee Park, BA1, Ryeong Hyun Kim, BA1, Jin Hyuk Kim, BA1, Hyun Jung Kim, BS1, Hyeong Soo Nam, PhD4, Wang-Yuhl Oh, PhD4, Kyeongsoon Park, PhD3, Hongki Yoo, PhD4, and Jin Won Kim, MD, PhD1,2
1Multimodal Imaging and Theranostic Lab, Cardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea, 2Cardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea, 3Department of Systems Biotechnology, Chung-Ang University, Anseong, Republic of Korea, 4Department of Mechanical Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Markers of Myocardial Damage Predict Mortality in Patients with Aortic Stenosis
[Speaker]
Soongu Kwak
Soongu Kwak, MD,1 Russell J. Everett, MD, PhD,2 Thomas A. Treibel, MD, PhD,3 Seokhun Yang, MD,1 Doyeon Hwang, MD,1 Heesun Lee, MD,1 Yong-Jin Kim, MD, PhD,1 Sahmin Lee, MD, PhD,4 Sung-Ji Park, MD, PhD,5 Martin Hadamitzky, MD,6 Bernhard L. Gerber, MD, PhD,7 David E. Newby, MD, PhD,2 James C. Moon, MD,3 Marc R. Dweck, MD, PhD2, Seung-Pyo Lee, MD, PhD1 and ECV440 investigators.
1Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom, 3Barts Health NHS Trust and University College London, London, United Kingdom, 4Division of Cardiology, Asan Medical Center Heart Institute, University of Ulsan College of Medicine, Seoul, South Korea, 5Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 6Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany, 7Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc and Institut de Recherche Cardiovasculaire (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium
[Speaker]
Ah Young Kim
Ah Young Kim1, Jung Min Park1, Yoo Rim Shin2, Han Ki Park2, Young-Hwan Park2, Se Yong Jung1, Jo Won Jung1, Jae Young Choi1
1 Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
2 Division of Cardiovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
[Speaker]
Da Eun Roh
Da Eun Roh1, Jung Eun Kwon1, Young Tae Lim1, Yeo Hyang Kim1
1Department of Pediatrics, School of Medicine, Kyungpook National University, Division of Pediatric Cardiology, Kyungpook National University Children’s hospital, Daegu, Republic of Korea
ADAM10 inhibits the Interaction between IL-17 and HMGB1 in Buerger's Disease
[Speaker]
Jae Kyeong Byun
Jae Kyeong Byun1, Kyung-Hee Kim2, Seung-Woon Rha3, Yoonjee Park4, Jin Ah Cha1,5, Se Yeon Choi1, Byoung Geol Choi1, Cheol Ung Choi3
1Cardiovascular Research Institute, Korea University, Seoul, Korea
2Division of Cardiology, Mediplex Sejong Hosptial, Incheon, Republic of Korea
3Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea
4Cardiovascular Center, Samsung Medical Center, Seoul, Republic of Korea
5BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea
[Speaker]
Dohee Yoon
Dohee Yoon1,2, Bongkun Choi1,2, Sujin Kim3,4, Jae-Kwan Song4,*, Eun-Ju Chang1,2,5,*
1Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
2Stem Cell Immunomodulation Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
3College of Nursing, Yonsei University, Seoul, Korea.
4Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
5Department of Biochemistry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
*These authors contributed equally to this study.